SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015454
Filing Date
2024-05-09
Accepted
2024-05-09 07:00:58
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr20240331_10q.htm   iXBRL 10-Q 706512
2 EXHIBIT 31.1 ex_632565.htm EX-31.1 13257
3 EXHIBIT 31.2 ex_632566.htm EX-31.2 13242
4 EXHIBIT 32.1 ex_632567.htm EX-32.1 8414
  Complete submission text file 0001437749-24-015454.txt   3786919

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240331.xsd EX-101.SCH 32787
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20240331_cal.xml EX-101.CAL 20102
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240331_def.xml EX-101.DEF 237683
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240331_lab.xml EX-101.LAB 221341
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240331_pre.xml EX-101.PRE 257063
56 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240331_10q_htm.xml XML 515703
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 24928471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)